259 related articles for article (PubMed ID: 17690889)
1. Biomarkers for prostate cancer.
Schiffer E
World J Urol; 2007 Dec; 25(6):557-62. PubMed ID: 17690889
[TBL] [Abstract][Full Text] [Related]
2. The role of proteomics in prostate cancer research: biomarker discovery and validation.
Pin E; Fredolini C; Petricoin EF
Clin Biochem; 2013 Apr; 46(6):524-38. PubMed ID: 23266295
[TBL] [Abstract][Full Text] [Related]
3. Proteomics in diagnosis of prostate cancer.
Davalieva K; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
[TBL] [Abstract][Full Text] [Related]
4. Proteomics in prostate cancer.
Bañez LL; Srivastava S; Moul JW
Curr Opin Urol; 2005 May; 15(3):151-6. PubMed ID: 15815190
[TBL] [Abstract][Full Text] [Related]
5. In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice.
Katafigioti A; Katafigiotis I; Sfoungaristos S; Alamanis C; Stravodimos K; Anastasiou I; Roumelioti E; Duvdevani M; Constantinides C
Arch Ital Urol Androl; 2016 Oct; 88(3):195-200. PubMed ID: 27711093
[TBL] [Abstract][Full Text] [Related]
6. Innovative biomarkers for prostate cancer early diagnosis and progression.
You J; Cozzi P; Walsh B; Willcox M; Kearsley J; Russell P; Li Y
Crit Rev Oncol Hematol; 2010 Jan; 73(1):10-22. PubMed ID: 19328712
[TBL] [Abstract][Full Text] [Related]
7. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of prostate cancer by analyzing oxidative stress in human seminal plasma: developing unsophisticated tools for noninvasive prostate cancer diagnosis.
Barrio-Muñoz M; Abad-Gairín C; Amengual-Guedán JM; Prats-López J
Eur J Cancer Prev; 2016 Nov; 25(6):518-23. PubMed ID: 26633164
[TBL] [Abstract][Full Text] [Related]
9. Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients.
Drabovich AP; Saraon P; Drabovich M; Karakosta TD; Dimitromanolakis A; Hyndman ME; Jarvi K; Diamandis EP
Mol Cell Proteomics; 2019 Sep; 18(9):1807-1823. PubMed ID: 31249104
[TBL] [Abstract][Full Text] [Related]
10. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
[TBL] [Abstract][Full Text] [Related]
11. Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer.
Böttcher R; Hoogland AM; Dits N; Verhoef EI; Kweldam C; Waranecki P; Bangma CH; van Leenders GJ; Jenster G
Oncotarget; 2015 Feb; 6(6):4036-50. PubMed ID: 25686826
[TBL] [Abstract][Full Text] [Related]
12. [Update on the diagnosis of PCa in urine. The current role of urine markers].
Fernandez-Serra A; Casanova-Salas I; Rubio L; Calatrava A; García-Flores M; García-Casado Z; López-Guerrero JA; Rubio-Briones J
Arch Esp Urol; 2015 Apr; 68(3):240-9. PubMed ID: 25948797
[TBL] [Abstract][Full Text] [Related]
13. Use of multiple biomarkers for a molecular diagnosis of prostate cancer.
Landers KA; Burger MJ; Tebay MA; Purdie DM; Scells B; Samaratunga H; Lavin MF; Gardiner RA
Int J Cancer; 2005 May; 114(6):950-6. PubMed ID: 15609297
[TBL] [Abstract][Full Text] [Related]
14. The utility of urine-circulating miRNAs for detection of prostate cancer.
Stuopelyte K; Daniunaite K; Bakavicius A; Lazutka JR; Jankevicius F; Jarmalaite S
Br J Cancer; 2016 Sep; 115(6):707-15. PubMed ID: 27490805
[TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Prognosis and Prediction Markers in Advanced Prostate Cancer Tissues Based on Quantitative Proteomics.
Kwon OK; Ha YS; Na AY; Chun SY; Kwon TG; Lee JN; Lee S
Cancer Genomics Proteomics; 2020; 17(2):195-208. PubMed ID: 32108042
[TBL] [Abstract][Full Text] [Related]
16. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.
Zarovni N; Corrado A; Guazzi P; Zocco D; Lari E; Radano G; Muhhina J; Fondelli C; Gavrilova J; Chiesi A
Methods; 2015 Oct; 87():46-58. PubMed ID: 26044649
[TBL] [Abstract][Full Text] [Related]
17. The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications.
Blute ML; Damaschke NA; Jarrard DF
Curr Opin Urol; 2015 Jan; 25(1):83-8. PubMed ID: 25405932
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
Guo J; Wang M; Wang Z; Liu X
PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis.
Han ZD; Zhang YQ; He HC; Dai QS; Qin GQ; Chen JH; Cai C; Fu X; Bi XC; Zhu JG; Liao DJ; Lu XP; Mo ZY; Zhu YP; Zhong WD
Med Oncol; 2012 Dec; 29(4):2877-88. PubMed ID: 22215415
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic scoring system for prostate cancer using urine and plasma biomarkers.
Ma W; Diep K; Fritsche HA; Shore N; Albitar M
Genet Test Mol Biomarkers; 2014 Mar; 18(3):156-63. PubMed ID: 24512523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
